Abstract
Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is one of the rarest and most serious headache disorders. Cases of symptomatic SUNCT syndromes are reported, which demonstrate that brain imaging is very important for diagnosis. In this study, we describe the first case of secondary SUNCT syndrome caused by a meningioma. So far, a clearly effective therapy for SUNCT syndrome has not been known. In this case, however, SUNCT was completely responsive to gabapentin. This underlines that this drug is worthy of being considered as a potential therapeutic option in the treatment of SUNCT syndrome.
Highlights
Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is an extremely rare form of headache
We describe the first case of secondary SUNCT syndrome caused by a meningioma
We report a case of secondary SUNCT syndrome caused by a meningioma fully responsive to gabapentin
Summary
Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is an extremely rare form of headache. It is characterized by short attacks of unilateral neuralgiform severe pain accompanied by autonomic symptoms such as tearing, rhinorrhea and conjunctival injection [1,2,3]. SUNCT is a subset of SUNA (short-lasting unilateral neuralgiform headache attacks with cranial autonomic features) that shows similar headache attacks, but different cranial autonomic symptoms [4]. Several symptomatic SUNCT syndromes caused by intracerebral tumors and non-tumorous lesions are reported. We report a case of secondary SUNCT syndrome caused by a meningioma fully responsive to gabapentin
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
